Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy.

[1]  Xianglin L. Du,et al.  Risks of Major Long‐Term Side Effects Associated with Androgen‐Deprivation Therapy in Men with Prostate Cancer , 2018, Pharmacotherapy.

[2]  S. Lipsitz,et al.  Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer , 2018, The Journal of urology.

[3]  A. Adler,et al.  Depression among military spouses: Demographic, military, and service member psychological health risk factors , 2018, Depression and anxiety.

[4]  A. D'Amico,et al.  Association Between Androgen Deprivation Therapy and Patient‐reported Depression in Men With Recurrent Prostate Cancer , 2018, Clinical genitourinary cancer.

[5]  A. Kibel,et al.  Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta‐Analysis , 2018, The Journal of urology.

[6]  D. Brody,et al.  Prevalence of Depression Among Adults Aged 20 and Over: United States, 2013-2016. , 2018, NCHS data brief.

[7]  C. Andrade.  Age as a variable: Continuous or categorical? , 2017, Indian journal of psychiatry.

[8]  W. Milberg,et al.  Elevated rates of memory impairment in military service-members and veterans with posttraumatic stress disorder , 2017, Journal of clinical and experimental neuropsychology.

[9]  A. Cole,et al.  Secondary data analysis: techniques for comparing interventions and their limitations , 2017, Current opinion in urology.

[10]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. , 2017, European urology.

[11]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[12]  A. Aprikian,et al.  Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Fowler,et al.  Immortal time bias in observational studies of time-to-event outcomes. , 2016, Journal of critical care.

[14]  Jim C Hu,et al.  Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Joel T Dudley,et al.  Androgen Deprivation Therapy and Future Alzheimer's Disease Risk. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Menon,et al.  Dose‐dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events , 2016, BJU international.

[17]  Hsiu-Chen Lin,et al.  Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with prostate cancer , 2016, Andrology.

[18]  C. Meyer,et al.  Relationship between androgen deprivation therapy and community‐acquired respiratory infections in patients with prostate cancer , 2016, International journal of urology : official journal of the Japanese Urological Association.

[19]  M. Menon,et al.  Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer. , 2015, European urology.

[20]  Jong Y. Park,et al.  Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  F. Saad,et al.  Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based study. , 2015, Clinical genitourinary cancer.

[22]  M. Hasnain,et al.  Possible role of vascular risk factors in Alzheimer's disease and vascular dementia. , 2014, Current pharmaceutical design.

[23]  A. Bertelsen,et al.  A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. , 2014, JAMA psychiatry.

[24]  R. Kessler,et al.  Prevalence and correlates of suicidal behavior among soldiers: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). , 2014, JAMA psychiatry.

[25]  P. Austin.  The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments , 2013, Statistics in medicine.

[26]  M. Carta,et al.  Epidemiology of early-onset dementia: a review of the literature , 2013, Clinical practice and epidemiology in mental health : CP & EMH.

[27]  K. Noyes,et al.  Medicare beneficiaries with depression: comparing diagnoses in claims data with the results of screening. , 2011, Psychiatric services.

[28]  P. Austin.  Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.

[29]  S. Kennedy,et al.  Calculated bioavailable testosterone levels and depression in middle-aged men , 2006, Psychoneuroendocrinology.

[30]  Hilkka Soininen,et al.  Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study , 2006, The Lancet Neurology.

[31]  D. Kivlahan,et al.  Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. , 2005, The Journal of clinical psychiatry.

[32]  D. Petrylak,et al.  Complications of androgen deprivation therapy in men with prostate cancer , 2004, Current urology reports.

[33]  L. Mucke,et al.  Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits , 2002, The Journal of Neuroscience.

[34]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[35]  T. Kostić,et al.  Erectile dysfunction as a predictor of two-year prognosis in acute myocardial infarction. , 2017, Cardiology Journal.